Overactivation of mitogen-activated protein kinase and suppression of mitofusin-2 expression are two independent events in high mobility group box 1 protein-mediated T cell immune dysfunction

Journal of Interferon and Cytokine Research

Volumn 33, Issue 9, 2013, Pages 529-541

  Lu, Zhong Qiu ^a   Tang, Lu Ming ^a,b   Zhao, Guang Ju ^a   Yao, Yong Ming ^c   Zhu, Xiao Mei ^c   Dong, Ning ^c   Yu, Yan ^c  

^a THE FIRST AFFILIATED HOSPITAL OF WENZHOU MEDICAL UNIVERSITY   (China)

^b THE SECOND AFFILIATED HOSPITAL AND YUYING CHILDREN S HOSPITAL OF WENZHOU MEDICAL UNIVERSITY   (China)

^c CHINESE PLA GENERAL HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; 4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; BETA ACTIN; GAMMA INTERFERON; HIGH MOBILITY GROUP B1 PROTEIN; INTERLEUKIN 2; INTERLEUKIN 4; MITOFUSIN 2; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38; TRANSCRIPTION FACTOR NFAT;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; ENZYME ACTIVATION; ENZYME INDUCTION; ENZYME PHOSPHORYLATION; IMMUNE RESPONSE; IMMUNOREGULATION; IMMUNOSTIMULATION; IN VITRO STUDY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SEPSIS; SIGNAL TRANSDUCTION; T LYMPHOCYTE; UPREGULATION;

CELL LINE; GENE EXPRESSION; GENE EXPRESSION REGULATION; GTP PHOSPHOHYDROLASES; HMGB1 PROTEIN; HUMANS; IMIDAZOLES; MITOCHONDRIAL PROTEINS; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; MITOGEN-ACTIVATED PROTEIN KINASES; NFATC TRANSCRIPTION FACTORS; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PROTEIN BINDING; PYRIDINES; SIGNAL TRANSDUCTION; T-LYMPHOCYTES;

EID: 84883706469     PISSN: 10799907     EISSN: 15577465     Source Type: Journal    
DOI: 10.1089/jir.2012.0054     Document Type: Article

References (45)

1. Ayala A, Deol ZK, Lehman DL, Herdon CD, Chaudry IH. 1994. Polymicrobial sepsis but not low-dose endotoxin infusion causes decreased splenocyte IL-2/IFN-[gamma] release while increasing IL-4/IL-10 production. J Surg Res 56(6):579-585.
2. Beals CR, Sheridan CM, Turck CW, Gardner P, Crabtree GR. 1997. Nuclear export of NF-ATc enhanced by glycogen synthase kinase-3. Science 275(5308):1930-1934.
3. Bulavin DV, Saito S, Hollander MC, Sakaguchi K, Anderson CW, et al. 1999. Phosphorylation of human p53 by p38 kinase coordinates N-terminal phosphorylation and apoptosis in response to UV radiation. EMBO J 18(23):6845-6854.
4. Chambard JC, Lefloch R, Pouysségur J, Lenormand P. 2007. ERK implication in cell cycle regulation. Biochim Biophys Acta 1773(8):1299-1310.
5. Chang L, Karin M. 2001. Mammalian MAP kinase signalling cascades. Nature 410(6824):37-40.
6. Chen KH, Guo X, Ma D, Guo Y, Li Q, et al. 2004. Dysregulation of HSG triggers vascular proliferative disorders. Nat Cell Biol 6(9):872-883.
7. Chen RE, Thorner J. 2007. Function and regulation in MAPK signaling pathways: lessons learned from the yeast Saccharomyces cerevisiae. Biochim Biophys Acta 1773(8):1311-1340.
8. Chow CW, Dong C, Flavell RA, Davis RJ. 2000. c-Jun NH(2)-terminal kinase inhibits targeting of the protein phosphatase calcineurin to NFATc1. Mol Cell Biol 20(14):5227-5234.
9. Cobb MH, Boulton TG, Robbins DJ. 1991. Extracellular signalregulated kinases: ERKs in progress. Cell Regul 2(12):965-978.
10. de Brito OM, Scorrano L. 2008. Mitofusin 2: a mitochondriashaping protein with signaling roles beyond fusion. Antioxid Redox Signal 10(3):621-633.
11. DeSilva DR, Jones EA, Favata MF, Jaffee BD, Magolda RL, et al. 1998. Inhibition of mitogen-activated protein kinase kinase blocks T cell proliferation but does not induce or prevent anergy. J Immunol 160(9):4175-4181.
12. Dodeller F, Skapenko A, Kalden JR, Lipsky PE, Schulze-Koops H. 2005. The p38 mitogen-activated protein kinase regulates effector functions of primary human CD4 T cells. Eur J Immunol 35(12):3631-3642.
13. Ferguson NR, Galley HF, Webster NR. 1999. T helper cell subset ratios in patients with severe sepsis. Intensive Care Med 25(1):106-109.
14. Fiuza C, Bustin M, Talwar S, Tropea M, Gerstenberger E, et al. 2003. Inflammatory promoting activity of HMGB1 on human microvascular endothelial cells. Blood 101(7):2652-2660.
15. Heidecke CD, Hensler T, Weighardt H, Zantl N, Wagner H, et al. 1999. Selective defects of T lymphocyte function in patients with lethal intraabdominal infection. Am J Surg 178(4):288-292.
16. Hildesheim J, Bulavin DV, Anver MR, Alvord WG, Hollander MC, et al. 2002. Gadd45a protects against UV irradiation-induced skin tumors, and promotes apoptosis and stress signaling via MAPK and p53. Cancer Res 62(24):7305-7315.
17. Huang W, Alessandrini A, Crews CM, Erikson RL. 1993. Raf-1 forms a stable complex with Mek1 and activates Mek1 by serine phosphorylation. Proc Natl Acad Sci USA 90(23):10947-10951.
18. Huang W, Tang Y, Li L. 2010. HMGB1, a potent proinflammatory cytokine in sepsis. Cytokine 51(2):119-126.
19. Huttunen HJ, Fages C, Rauvala H. 1999. Receptor for advanced glycation end products (RAGE)-mediated neurite outgrowth and activation of NF-kappaB require the cytoplasmic domain of the receptor but different downstream signaling pathways. J Biol Chem 274(28):19919-19924.
20. Kerksiek KM, Pamer EG. 1999. T cell responses to bacterial infection. Curr Opin Immunol 11(4):400-405.
21. Kitamura N, Kaminuma O, Mori A, Hashimoto T, Kitamura F, et al. 2005. Correlation between mRNA expression of Th1/Th2 cytokines and their specific transcription factors in human helper T-cell clones. Immunol Cell Biol 83(5):536-541.
22. Lantos J, Fö ldi V, Roth E, Wéber G, Bogár L, et al. 2010. Burn trauma induces early HMGB1 release in patients: its correlation with cytokines. Shock 33(6):562-567.
23. Nel AE. 2002. T-cell activation through the antigen receptor. Part 1: signaling components, signaling pathways, and signal integration at the T-cell antigen receptor synapse. J Allergy Clin Immunol 109(5):758-770.
24. Oberholzer A, Oberholzer C, Moldawer LL. 2001. Sepsis syndromes: understanding the role of innate and acquired immunity. Shock 16(2):83-96.
25. O'Sullivan ST, Lederer JA, Horgan AF, Chin DH, Mannick JA, et al. 1995. Major injury leads to predominance of the T helper-2 lymphocyte phenotype and diminished interleukin-12 production associated with decreased resistance to infection. Ann Surg 222(4):482-490.
26. Oukka M, Ho IC, de la Brousse FC, Hoey T, Grusby MJ, et al. 1998. The transcription factor NFAT4 is involved in the generation and survival of T cells. Immunity 9(3):295-304.
27. Patenaude J, D'Elia M, Hamelin C, Garrel D, Bernier J. 2005. Burn injury induces a change in T cell homeostasis affecting preferentially CD4+ T cells. J Leukoc Biol 77(2):141-150.
28. Phan HH, Cho K, Nelson HA, Shin S, Jeong J, et al. 2005. Downregulation of NF-kappaB activity associated with alteration in proliferative response in the spleen after burn injury. Shock 23(1):73-79.
29. Ray LB, Sturgill TW. 1988. Insulin-stimulated microtubule-associated protein kinase is phosphorylated on tyrosine and threonine in vivo. Proc Natl Acad Sci USA 85(11):3753-3757.
30. Rincón M, Enslen H, Raingeaud J, Recht M, Zapton T, et al. 1998. Interferon-gamma expression by Th1 effector T cells mediated by the p38 MAP kinase signaling pathway. EMBO J 17(10): 2817-2829.
31. Rincón M, Flavell RA, Davis RA. 2000. The JNK and P38 MAP kinase signaling pathways in T cell-mediated immune responses. Free Radic Biol Med 28(9):1328-1337.
32. Rincón M, Pedraza-Alva G. 2003. JNK and p38 MAP kinases in CD4+ and CD8+ T cells. Immunol Rev 192(1):131-142.
33. Sanchez-Prieto R, Sanchez-Arevalo VJ, Servitja JM, Gutkind JS. 2002. Regulation of p73 by c-Abl through the p38 MAP kinase pathway. Oncogene 21(6):974-979.
34. Seger R, Krebs EG. 1995. The MAPK signaling cascade. FASEB J 9(9):726-735.
35. Shen T, Zheng M, Cao C, Chen C, Tang J, et al. 2007. Mitofusin-2 is a major determinant of oxidative stress-mediated heart muscle cell apoptosis. J Biol Chem 282(32):23354-23361.
36. Sir O, Fazal N, Choudhry MA, Goris RJ, Gamelli RL, et al. 2000. Role of neutrophils in burn-induced microvascular injury in the intestine. Shock 14(2):113-117.
37. Taguchi A, Blood DC, del Toro G, Canet A, Lee DC, et al. 2000. Blockade of RAGE-amphoterin signalling suppresses tumour growth and metastases. Nature 405(6784):354-360.
38. Versteeg HH, Nijhuis E, van den Brink GR, Evertzen M, Pynaert GN, et al. 2000. A new phosphospecific cell-based ELISA for p42/p44 mitogen-activated protein kinase (MAPK), p38 MAPK, protein kinase B and cAMP-response-element- binding protein. Biochem J 350(Pt 3):717-722.
39. Wang H, Bloom O, Zhang M, Vishnubhakat JM, Ombrellino M, et al. 1999. HMG-1 as a late mediator of endotoxin lethality in mice. Science 285(5425):248-251.
40. Yang D, Chen Q, Yang H, Tracey KJ, Bustin M, et al. 2007. High mobility group box-1 protein induces the migration and activation of human dendritic cells and acts as an alarmin. J Leukoc Biol 81(1):59-66.
41. Yao YM, Lin HY. 2008. The potential role of high mobility group box 1 protein in immune dysfunction and its regulatory mechanism after major trauma. Zhongguo Wei Zhong Bing Ji Jiu Yi Xue 20(9):513-515.
42. Zetterström CK, Bergman T, Rynnel-Dagöö B, Erlandsson Harris H, Soder O, et al. 2002. High mobility group box chromosomal protein 1 (HMGB1) is an antibacterial factor produced by the human adenoid. Pediatr Res 52(2):148-154.
43. Zhang LT, Yao YM, Dong YQ, Dong N, Yu Y, et al. 2008. Relationship between high-mobility group box 1 protein release and T-cell suppression in rats after thermal injury. Shock 30(4):449-455.
44. Zhang YL, Dong C. 2005. MAP kinases in immune responses. Cell Mol Immunol 2(1):20-27.
45. Zhao GJ, Yao YM, Lu ZQ, Hong GL, Zhu XM, et al. 2012. Upregulation of mitofusin-2 protects CD4+ T cells from HMGB1-mediated immune dysfunction partly through Ca2 +-NFAT signaling pathway. Cytokine 59(1):79-85.